Accueil   Diary - News   All news Imaxio sells Trolovol®

Imaxio sells Trolovol®

Imaxio sells Trolovol® (D-penicillamine) to focus on vaccines

 

This divestment enables Imaxio to focus exclusively on the development of its pipeline of vaccine candidates based on the IMX313 technology, and on the commercialisation of the vaccine Spirolept®

 

Read the press release